Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Churchill Capital Corp XI - Class A Ordinary Shares (NQ:CCXI)

17.03 -0.03 (-0.18%)

Streaming Delayed Price Updated: 11:00 AM EDT, Jul 2, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	1,848,650
Open	17.35
Bid (Size)	17.01 (800)
Ask (Size)	17.20 (2,600)
Prev. Close	17.06
Today's Range	16.92 - 17.75
52wk Range	10.07 - 19.62
Shares Outstanding	71,355,872
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Agility Robotics’ SPAC Deal Opens a Rare Door Into Humanoid AI ↗

Today 9:55 EDT

The CCXI-Agility Robotics SPAC merger will create the first U.S.-listed pure-play humanoid equity, valued at $2.5B, with clients including Amazon and a NVIDIA partnership.

Via MarketBeat

On Wednesday, there are stocks with unusual volume. Let's take a look. ↗

July 01, 2026

Via Chartmill

Performance

YTD	+66.0%	+66.0%
1 Month	+66.5%	+66.5%
3 Month	+67.8%	+67.8%
6 Month	+66.0%	+66.0%
1 Year	+66.0%	+66.0%

More News

The trading volume of these stocks is deviating from the norm in today's session. ↗

June 30, 2026

Via Chartmill

The trading volume of these stocks is deviating from the norm in today's session. ↗

June 29, 2026

Via Chartmill

The trading volume of these stocks is deviating from the norm in today's session. ↗

June 26, 2026

Via Chartmill

These stocks have an unusual volume in today's session ↗

June 25, 2026

Via Chartmill

Agility Robotics to Go Public Through $2.5 Billion Merger with Churchill Capital Corp XI

June 24, 2026

From Agility Robotics, Inc.

Via Business Wire

Two Down With Sanofi Bowing Out From Horizon Buyout Talks, Amgen Agrees To Buy For $116.5/Share ↗

December 12, 2022

Via Benzinga

How to Trade the High-Growth Biotech Sector in the Midst of a Bear Market ↗

November 23, 2022

Via Benzinga

ChemoCentryx Announces Presentations at the 2022 American Society of Nephrology and American College of Rheumatology Annual Meetings

October 17, 2022

From ChemoCentryx, Inc.

Via GlobeNewswire

Biotech Stocks Well-Positioned For The Fourth Quarter ↗

October 12, 2022

Via Talk Markets

ChemoCentryx Announces Upcoming Presentations for Orally Administered PD-L1 Inhibitor, CCX559, at the 2022 Society for Immunotherapy of Cancer (SITC) Annual Meeting

October 05, 2022

From ChemoCentryx, Inc.

Via GlobeNewswire

These Were the Five Best And Worst Performing Mid-Cap Stocks In August 2022 ↗

September 20, 2022

Via Talk Markets

Here Are 10 Biotech Stocks — Including Catalyst And Viridian — That Would Have Netted You $10,000 More This Year ↗

September 19, 2022

Via Investor's Business Daily

Something Unusual Is Happening Right Now With Biotech Stocks Like Catalyst, Vertex, Neurocrine And BioMarin ↗

September 15, 2022

Via Investor's Business Daily

INVESTIGATION ALERT: Scott+Scott Attorneys at Law LLP Investigates ChemoCentryx, Inc.’s Directors and Officers for Breach of Fiduciary Duties – CCXI

September 13, 2022

From Scott+Scott Attorneys at Law LLP

Via Business Wire

7 Dow Stocks With Superior Fundamentals ↗

September 06, 2022

Via InvestorPlace

Healthcare Sector Still Looks Good But Lacks Momentum ↗

September 06, 2022

Via Talk Markets

ChemoCentryx's Return On Capital Employed Insights ↗

September 01, 2022

Via Benzinga

INVESTIGATION ALERT: Scott+Scott Attorneys at Law LLP Investigates ChemoCentryx, Inc.’s Directors and Officers for Breach of Fiduciary Duties – CCXI

August 30, 2022

From Scott+Scott Attorneys at Law LLP

Via Business Wire

10 Biotech Stocks Are Up 40% Or More This Year, Including Karuna, Axsome And Others ↗

August 29, 2022

Via Investor's Business Daily

Whither Small Caps After Fed’s Tough Talk? ↗

August 29, 2022

Via Talk Markets

Blistering-Hot Biotech Shopping Spree Continues: Alcon To Buy Aerie For $770 Million ↗

August 23, 2022

Via Investor's Business Daily

Check your Portfolio for Small Cap Weighting: Growth, Innovation or Speculation? ↗

August 15, 2022

Via Talk Markets

Why Jim Cramer Says This Financial Stock Is 'Terrific' ↗

August 12, 2022

Via Benzinga

Frequently Asked Questions

Is Churchill Capital Corp XI - Class A Ordinary Shares publicly traded?

Yes, Churchill Capital Corp XI - Class A Ordinary Shares is publicly traded.

What exchange does Churchill Capital Corp XI - Class A Ordinary Shares trade on?

Churchill Capital Corp XI - Class A Ordinary Shares trades on the Nasdaq Stock Market

What is the ticker symbol for Churchill Capital Corp XI - Class A Ordinary Shares?

The ticker symbol for Churchill Capital Corp XI - Class A Ordinary Shares is CCXI on the Nasdaq Stock Market

What is the current price of Churchill Capital Corp XI - Class A Ordinary Shares?

The current price of Churchill Capital Corp XI - Class A Ordinary Shares is 17.03

When was Churchill Capital Corp XI - Class A Ordinary Shares last traded?

The last trade of Churchill Capital Corp XI - Class A Ordinary Shares was at 07/02/26 11:00 AM ET

What is the market capitalization of Churchill Capital Corp XI - Class A Ordinary Shares?

The market capitalization of Churchill Capital Corp XI - Class A Ordinary Shares is 1.22B

How many shares of Churchill Capital Corp XI - Class A Ordinary Shares are outstanding?

Churchill Capital Corp XI - Class A Ordinary Shares has 1B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.